Upgrade to SI Premium - Free Trial

Raymond James: 'We continue to like EHC as it is a solid compounder of earnings'

April 15, 2026 9:37 AM
Raymond James analyst John Ransom reiterated a Strong Buy rating and $130.00 price target on Encompass Health Corp (NYSE: EHC).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments